Not finding it? Sign in to also search OpenAlex live.
-
Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia Is an Effective, Low Toxic TBI-Free Conditioning Regimen2020 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access
A. Birgitta Versluijs, Coco C. H. de Koning, Arjan C. Lankester, Dorine Bresters, Wouter J.W. Kollen, Caroline A. Lindemans, +3 more
0citations -
Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT2021 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Giorgia Battipaglia, Katya A. L. Mauff, Lotus Wendel, Emanuele Angelucci, Mohamad Mohty, William Arcese, +20 more
18citations -
Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome (MDS) Using Treosulfan Based Compared to Standard Reduced-Intensity or Myeloablative Conditioning Regimens. a Report of the Chronic Malignancies Working Party of EBMT2020 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access
Avichai Shimoni, Marie Robin, Simona Iacobelli, Anja van Biezen, Dietrich Wilhelm Beelen, Ghulam J. Mufti, +12 more
0citations -
Busulfan–fludarabine‐ or treosulfan–fludarabine‐based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties
Annamária Cseh, Jacques‐Emmanuel Galimard, Josu de la Fuente, Antonella Isgrò, Marco Zecca, Birgit Garwer, +14 more
8citations -
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT
Avichai Shimoni, Marie Robin, Simona Iacobelli, Dietrich Wilhelm Beelen, Ghulam J. Mufti, Fabio Ciceri, +12 more
25citations -
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia2025 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Klaus Wethmar, Matthias Edinger, Kerstin Schäfer‐Eckart, Matthias Stelljes, Thomas A. Schroeder, Kristina Sohlbach, +13 more
3citations -
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
Agnieszka Tomaszewska, Madan Jagasia, Eric Beohou, Steffie Maria van der Werf, Didier Blaise, Edward Kanfer, +26 more
6citations -
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study2020 Journal of Clinical Oncology article Medicine Hematopoietic Stem Cell Transplantation Open access
Christina Peters, Jean‐Hugues Dalle, Franco Locatelli, Ulrike Pöetschger, Petr Sedláček, Jochen Buechner, +25 more
343citations -
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Köster, Dirk‐Jan Eikema, Anja van Biezen, Friedrich Stölzel, +10 more
12citations -
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT
Meral Beksaç, Dirk‐Jan Eikema, Linda Köster, Cyrille Hulin, Xavier Poiré, Rose‐Marie Hamladji, +19 more
0citations -
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT2023 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Victoria T. Potter, Luuk A. Gras, Nicolaus Martin Kröger, Katja Sockel, Arnold Ganser, Jürgen Finke, +18 more
10citations -
Sequential vs Myeloablative vs Reduced Intensity Conditioning for Patients with Myelodysplastic Syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: A Retrospective Study by the Chronic Malignancies Working Party of the EBMT
Victoria T. Potter, Luuk A. Gras, Anja van Biezen, Nicolaus Martin Kröger, Katja Sockel, Arnold Ganser, +18 more
0citations -
Treosulfan conditioning for allogeneic transplantation in multiple myeloma – improved overall survival in first line haematopoietic stem cell transplantation – a large retrospective study by the Chronic Malignancies Working Party of the EBMT2020 British Journal of Haematology article Medicine Multiple Myeloma Research and Treatments Open access
Charlotte Gran, Junfeng Wang, Hareth Nahi, Linda Köster, Gösta Gahrton, Hermann Einsele, +14 more
14citations -
Correction: Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens2021 Bone Marrow Transplantation erratum Medicine Hematopoietic Stem Cell Transplantation Open access
Birgitta A. B. Versluys, Jaap Jan Boelens, Cornelis Jan Pronk, Arjen C. Lankester, Victoria Bordon, Jochen Buechner, +6 more
0citations -
Conditioning Intensity in Patients Aged > 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
Noureddine Loukili, Luuk A. Gras, Linda Köster, Didier Blaise, Tobias Gedde‐Dahl, Johan A. Maertens, +19 more
0citations -
Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMT2025 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Noureddine Loukili, Luuk A. Gras, Linda Köster, Didier Blaise, Tobias Gedde‐Dahl, Johan A. Maertens, +17 more
2citations -
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT2025 Bone Marrow Transplantation article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Patryk Sobieralski, Tomasz Czerw, Luuk A. Gras, Linda Köster, Nicolaus Martin Kröger, Thomas A. Schroeder, +19 more
5citations -
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT2021 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Tomasz Czerw, Simona Iacobelli, Vittoria Carolina Malpassuti, Linda Köster, Nicolaus Martin Kröger, Marie Robin, +19 more
14citations